In Vitro Cytotoxic Effects and Mechanisms of Action of Eleutherine Isolated from Eleutherine plicata Bulb in Rat Glioma C6 Cells
Authors:
- Victoria Mae Tsuruzaki ShinkaiVSVictoria Mae Tsuruzaki Shinkai
- Izana Marize Oliveira SampaioISIzana Marize Oliveira Sampaio
- Eline Gomes dos SantosESEline Gomes dos Santos
- Adan Jesús Galué-ParraAGAdan Jesús Galué-Parra
- Dionisia Pelaes FerreiraDFDionisia Pelaes Ferreira
- Drielly Dayanne Monteiro Santos BalizaDBDrielly Dayanne Monteiro Santos Baliza
- Neidiane Farias RamosNRNeidiane Farias Ramos
- Raphael Sanzio PimentaRPRaphael Sanzio Pimenta
- Rommel Mario Rodriguez BurbanoRommel Mario Rodriguez Burbano
- Chubert Bernardo Castro SenaCSChubert Bernardo Castro Sena
- Barbarella Matos MacchiBMBarbarella Matos Macchi
- Irlon Maciel FerreiraIrlon Maciel Ferreira
Open Access
- 13 December 2022
- Vol. 27 (24) , 8850
Abstract
Gliomas are the most common primary malignant brain tumors in adults, and have a poor prognosis, despite the different types of treatment available. There is growing demand for new therapies to treat this life-threatening tumor. Quinone derivatives from plants have received increased interest as potential anti-glioma drugs, due to their diverse pharmacologic activities, such as inhibiting cell growth, inflammation, tumor invasion, and promoting tumor regression. Previous studies have demonstrated the anti-glioma activity of Eleutherine plicata, which is related to three main naphthoquinone compounds—eleutherine, isoeleutherine, and eleutherol—but their mechanism of action remains elusive. Thus, the aim of this study was to investigate the mechanism of action of eleutherine on rat C6 glioma. In vitro cytotoxicity was evaluated by MTT assay; morphological changes were evaluated by phase-contrast microscopy. Apoptosis was determined by annexin V–FITC–propidium iodide staining, and antiproliferative effects were assessed by wound migration and colony formation assays. Protein kinase B (AKT/pAKT) expression was measured by western blot, and telomerase reverse transcriptase mRNA was measured by quantitative real-time polymerase chain reaction (qRT-PCR). Eleutherine reduced C6 cell proliferation in a dose-dependent manner, suppressed migration and invasion, induced apoptosis, and reduced AKT phosphorylation and telomerase expression. In summary, our results suggest that eleutherine has potential clinical use in treating glioma.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (434501/2018-2)
- Fundação de Amparo a pesquisa do estado do Pará (063/2020)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Pró-Reitoria de Pesquisa e Pós-graduação (PROPESP-UFPA)
This publication has 49 references indexed in Scilit:
- Naphthoquinones, Anthraquinones and Naphthalene Derivatives from the Bulbs ofEleutherine americanaPlanta Medica, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Identifying and enumerating neural stem cells: application to aging and cancer2009
- Malignant Gliomas in AdultsNew England Journal of Medicine, 2008
- Epidemiology and molecular pathology of gliomaNature Clinical Practice Neurology, 2006
- Total synthesis of enantiopure 1,3-dimethylpyranonaphthoquinones including ventiloquinones E, G, L and eleutherinOrganic & Biomolecular Chemistry, 2006
- Validation of the 2-????Ct Calculation as an Alternate Method of Data Analysis for Quantitative PCR of BCR-ABL P210 TranscriptsDiagnostic Molecular Pathology, 2006
- Primary brain tumours in adultsThe Lancet, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Novel mechanisms of DNA topoisomerase II inhibition by pyranonaphthoquinone derivatives—eleutherin, α lapachone, and β lapachone∗Biochemical Pharmacology, 2000